Efficacy, safety and pharmacokinetics of Envarsus (a new formulation of Tacrolimus) in de novo liver transplanted patients

Trial Profile

Efficacy, safety and pharmacokinetics of Envarsus (a new formulation of Tacrolimus) in de novo liver transplanted patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Nov 2017

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Liver transplant rejection
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 17 Nov 2017 New trial record
    • 27 Sep 2017 Results presented at the 18th Congress of the European Society for Organ Transplantation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top